World Arthritis Day: improving the lives of people with rheumatic diseases
Posted by
12-Oct-2018
Today is World Arthritis Day. This annual event is designed to raise awareness of the symptoms connected to rheumatic and musculoskeletal diseases (RMDs) and the importance of early diagnosis and access to care.
The campaign is spearheaded by the European League Against Rheumatism (EULAR). It embraces all three pillars of the EULAR community: People against rheumatism in Europe (PARE), health professionals and scientific societies.
The key message is a simple one: Don't Delay, Connect Today. Launched in 2017, this campaign continues to attract a growing audience in Europe in 2018. It emphasizes the need for prompt diagnosis and treatment for people with RMDs. This is because when intervention comes too late, serious damage may already have been done to patients’ joints.
At UCB, we endorse this campaign and continue to play our part in improving care for people with RMDs, including rheumatoid arthritis, axial spondyloarthritis, and psoriatic arthritis. We want all people affected by these conditions to have timely access to evidence-based treatment. Not only has this the potential to prevent further damage, it can reduce the burden on individuals, their families and society.
On World Arthritis Day, and every day, UCB is committed to the goals of the rheumatology community. We aim to provide new innovative treatment options and to support people with severe immunological diseases in living beyond the constraints of their disease.
Find out more about World Arthritis Day
The campaign is spearheaded by the European League Against Rheumatism (EULAR). It embraces all three pillars of the EULAR community: People against rheumatism in Europe (PARE), health professionals and scientific societies.
The key message is a simple one: Don't Delay, Connect Today. Launched in 2017, this campaign continues to attract a growing audience in Europe in 2018. It emphasizes the need for prompt diagnosis and treatment for people with RMDs. This is because when intervention comes too late, serious damage may already have been done to patients’ joints.
At UCB, we endorse this campaign and continue to play our part in improving care for people with RMDs, including rheumatoid arthritis, axial spondyloarthritis, and psoriatic arthritis. We want all people affected by these conditions to have timely access to evidence-based treatment. Not only has this the potential to prevent further damage, it can reduce the burden on individuals, their families and society.
On World Arthritis Day, and every day, UCB is committed to the goals of the rheumatology community. We aim to provide new innovative treatment options and to support people with severe immunological diseases in living beyond the constraints of their disease.
Find out more about World Arthritis Day
Leave a Comment